Also trades as: ESLAW (NASDAQ) · $vol 0M
ESLA Earnings
Estrella Immunopharma, Inc.
1W: -2.7%
1M: -32.2%
3M: -54.1%
YTD: -66.3%
1Y: -65.1%
3Y: -95.7%
5Y: -95.2%
$0.47
-0.01 (-1.47%)
Weekly Expected Move ±12.3%
$0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-08-13
EPS
$-0.05
▲ Beat +44.4%
Revenue
—
EPS Beat Streak: 4 quarters
Next Earnings
2026-12-02
EPS Estimate
$-0.07
Range: $-0.07 - $-0.07
Estimate vs Actual
Earnings Surprise History
6/16
EPS Beats
0/16
Revenue Beats
38%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | annual | 2026-12-31 | $-0.29 | $-0.25 | ▲ 0.04 | $— | $— |
| 2026-08-31 | quarter | 2026-06-30 | $-0.09 | $-0.05 | ▲ 0.04 | $— | $— |
| 2026-08-14 | quarter | 2026-12-30 | $-0.12 | $-0.07 | ▲ 0.05 | $— | $— |
| 2026-07-20 | annual | 2026-12-31 | $-0.39 | $-0.29 | ▲ 0.10 | $— | $— |
| 2026-07-20 | annual | 2028-12-31 | $-0.23 | $-0.31 | ▼ 0.08 | $98,867,000 | $— |
| 2026-07-17 | quarter | 2026-06-30 | $-0.08 | $-0.09 | ▼ 0.01 | $— | $— |
| 2026-07-17 | quarter | 2026-09-30 | $-0.12 | $-0.08 | ▲ 0.04 | $— | $— |
| 2026-07-17 | quarter | 2026-12-31 | $-0.12 | $-0.07 | ▲ 0.05 | $— | $— |
| 2026-04-28 | quarter | 2026-03-31 | $-0.18 | $-0.08 | ▲ 0.10 | $— | $— |
| 2026-04-28 | quarter | 2026-06-30 | $-0.17 | $-0.08 | ▲ 0.09 | $— | $— |
| 2026-03-31 | annual | 2027-12-31 | $-0.39 | $-0.32 | ▲ 0.07 | $— | $— |
| 2026-03-30 | quarter | 2026-06-30 | $-0.12 | $-0.17 | ▼ 0.05 | $— | $— |
| 2026-03-30 | annual | 2027-12-31 | $-0.46 | $-0.39 | ▲ 0.07 | $— | $— |
| 2026-03-30 | annual | 2026-12-31 | $-0.41 | $-0.39 | ▲ 0.02 | $— | $— |
| 2026-03-30 | quarter | 2026-03-31 | $-0.13 | $-0.18 | ▼ 0.05 | $— | $— |
Earnings Call Transcripts
No transcripts available.